SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-047739
Filing Date
2015-08-10
Accepted
2015-08-10 16:14:23
Documents
12
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v416497_10q.htm 10-Q 434556
2 EXHIBIT 31.1 v416497_ex31-1.htm EX-31.1 8817
3 EXHIBIT 31.2 v416497_ex31-2.htm EX-31.2 8997
4 EXHIBIT 32.1 v416497_ex32-1.htm EX-32.1 4383
5 EXHIBIT 32.2 v416497_ex32-2.htm EX-32.2 4194
6 EXHIBIT 99.1 v416497_ex99-1.htm EX-99.1 179423
  Complete submission text file 0001144204-15-047739.txt   5572615

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT fbio-20150630.xml EX-101.INS 1308872
8 XBRL TAXONOMY EXTENSION SCHEMA fbio-20150630.xsd EX-101.SCH 48450
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fbio-20150630_cal.xml EX-101.CAL 40672
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fbio-20150630_def.xml EX-101.DEF 305856
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE fbio-20150630_lab.xml EX-101.LAB 387749
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fbio-20150630_pre.xml EX-101.PRE 361757
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 151040930
SIC: 2834 Pharmaceutical Preparations